Google News
logo
Daily Current Affairs
Which institute has started the trial of Mycobacterium w (Mw), an anti-leprosy drug on COVID-19 patients?
A)
Council of Scientific and Industrial Research
B)
Indian Council of Medical Research
C)
The Indian Institute of Technology
D)
All India Institute of Medical Sciences

Correct Answer :   Council of Scientific and Industrial Research


The Council of Scientific and Industrial Research (CSIR) has started the trial of Mycobacterium w (Mw), an anti-leprosy drug. The information was passed by the Director of CSIR Shekhar Mande. Under this one particular formulation, called "Mycobacterium w (Mw)", a heat-killed bacteria will be tried on different COVID-19 patients. CSIR has been granted approval to conduct the trial from the Drug Controller General of India (DCGI).

Published On : July 17, 2021
Advertisement